biologic

Albuminex

Albumin (Human)-kjda

Loss of exclusivityJune 2030projected — 12-year biologic exclusivity estimate
CompanyBio Products Laboratory Limited

Drug detail

Brand nameAlbuminex
Active ingredientAlbumin (Human)-kjda
Strength12.5G/250ML
Dosage formSolution
RouteIntravenous
ModalityBiologic
FDA approvalJune 2018
Marketing statusRx

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.

Albuminex patent cliff — loss of exclusivity June 2030 | CliffBio